JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2006; 48:21-31, doi:10.1016/j.jacc.2006.02.058 (Published online 8 June 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Online Table
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kereiakes, D. J.
Right arrow Articles by Moses, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kereiakes, D. J.
Right arrow Articles by Moses, J. W.

Periprocedural and Late Consequences of Overlapping Cypher Sirolimus-Eluting Stents

Pooled Analysis of Five Clinical Trials

Dean J. Kereiakes, MD, FACC*,*, Hong Wang, MD, MPH{dagger},a, Jeffrey J. Popma, MD{ddagger}, Richard E. Kuntz, MD{ddagger},d, Dennis J. Donohoe, MD{dagger},a, Joachim Schofer, MD§, Erick Schampaert, MD||, Bernhard Meier, MD, FESC, FACC,b, Martin B. Leon, MD, FACC#,c and Jeffrey W. Moses, MD, FACC#

* Heart Center of Greater Cincinnati and the Lindner Center for Research and Education at The Christ Hospital, Ohio Heart and Vascular Center Inc., Cincinnati, Ohio
{dagger} Cordis Corp., Warren, New Jersey
{ddagger} Brigham and Women’s Hospital, Boston, Massachusetts
§ Hamburg University Cardiovascular Center, Hamburg, Germany
|| Hospital du Sacre’-Coeur de Montreal, Montreal, Canada
Swiss Cardiovascular Center Bern, Bern, Switzerland
# Columbia University Medical Center, New York, New York


Figure 1
View larger version (44K):

[in a new window]
  		Figure 1 Late lumen loss by quantitative coronary angiography stratified by stent type, overlapped stent status, and region of interest. BMS = bare-metal stent; SES = sirolimus-eluting stent.

 

Figure 2
View larger version (22K):

[in a new window]
  		Figure 2 (A) Total myocardial infarction (MI) (both Q- and non–Q-wave) by stent type (bare-metal stents [BMS], n = 238; sirolimus-eluting stent [SES], n = 337) in patients treated with overlapping stents. (B) Incidence of total MI at 30 days by stent type stratified by total implanted stent length. (C) Total MI at 360 days by stent type stratified by total implanted stent length. Solid bars = BMS; open bars = SES.

 

Figure 3
View larger version (17K):

[in a new window]
  		Figure 3 Target lesion revascularization (TLR) and target vessel revascularization (TVR) through 360 days as well as target vessel failure (TVF) (composite occurrence of death, myocardial infarction, and TLR) stratified by stent type in patients treated with overlapping stents. BMS = bare metal stent; SES = sirolimus-eluting stent.

 

Figure 4
View larger version (18K):

[in a new window]
  		Figure 4 In-stent binary (>50%) angiographic restenosis (A) and target lesion revascularization (B) stratified by stent type and overlap (vs. single) stent status. *p < 0.0001 for comparisons sirolimus-eluting stent (SES) versus bare-metal stent (BMS) and BMS overlap versus single stent; p = 0.0016 for SES overlap versus single stent. {ddagger}p < 0.0001 for comparisons SES versus BMS; p = 0.0006 BMS overlap versus single stent; p = NS SES overlap versus single stent. Solid bars = BMS; open bars = SES.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2006 by the American College of Cardiology Foundation.